Study title: "The treatment of psoriasis capitis. Investigation of the efficacity of prednicarbate solution in comparison with commercially available, potent corticosteroid solution - M. Stander et al. - 1989 (Z. Hautkr vol 64) - Publication in Clinical Expert report : The topical Corticosteroid Prednicarbate - W. Schulz et al. - 10/ 1991-" "The treatment of psoriasis capitis. Investigation of the efficacity of prednicarbate solution in comparison with commercially available, potent corticosteroid solution - M. Stander et al. - 1989 (Z. Hautkr vol 64) - Publication in Clinical Expert report : The topical Corticosteroid Prednicarbate - W. Schulz et al. - 10/ 1991-"
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Skin and Connective Tissue Diseases | |||||
Brands: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: PREDNICARBATE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |